Other
FibroScan® test
FibroScan® test is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Active, not recruiting2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
active_not_recruiting267%
withdrawn133%
Recent Activity
2 active trials
Showing 3 of 3
withdrawn
Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
NCT05649202
active_not_recruitingnot_applicable
Screening and Intervention of MASLD in Children
NCT06905795
active_not_recruiting
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
NCT03432806
Clinical Trials (3)
Showing 3 of 3 trials
NCT05649202
Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
NCT06905795Not Applicable
Screening and Intervention of MASLD in Children
NCT03432806
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3